Lovable Lingerie (LOVABLE)
TurnaroundScore breakdown: P/E: 2/3 · ROCE: 0/2 · Growth: 2/2 · Dividend: 0/1
Key Financials
| Current Price | ₹72.7 |
| Market Cap | ₹107.6 Cr |
| P/E Ratio | 13.49 |
| ROCE | -1.74% |
| ROE | 1.97% |
| Dividend Yield | 0% |
| Profit Growth | -1.61% |
| Debt/Equity | 0.02 |
| Sales Growth | -16.95% |
| Promoter Holding | 63.95% |
| 52-Week Range | ₹55 — ₹104.7 |
| Sector | Textiles & Apparels |
| Book Value | ₹122.24 |
Strengths
- Trades at a ~29% discount to book value (P/B 0.71; price ₹84.81 vs book value ₹120.19), offering asset-backing margin of safety.
- Very low leverage with Debt/Equity of 0.02, reducing financial distress risk.
- Sales growth of 26.26% and profit growth of 212.50% indicate early operational revival.
- Promoter holding at 63.95% aligns management with minority shareholders.
- P/E of 15.51 is moderate, with the market assigning a reasonable multiple if the turnaround sustains.
Concerns
- ROE of only 1.97% and negative ROCE of -1.74% show weak capital efficiency and poor value creation.
- Profit growth of 212.50% is from a small base; latest quarter net profit is just ₹1 Cr, so earnings power is still limited.
- Zero dividend yield means investors get no income while waiting for operational improvement.
- No clear competitive moat or pricing power is evident from the numbers in a competitive garments/lingerie industry.
AI Analysis
At ₹84.81, this stock trades at a meaningful discount to book value of ₹120.19. With a market cap of ₹110 Cr and an implied equity book value around ₹155 Cr, the margin of safety on the balance sheet is clear. But cheapness alone is not enough. Return on equity is only 1.97%, and ROCE is negative at -1.74% — this business is not yet earning an acceptable return on the capital it employs. That is a red flag for a value investor. Still, there are signs of a turnaround: sales grew 26.26% and profit growth is 212.50%, although from a low base. The latest quarter shows ₹11 Cr sales and just ₹1 Cr net profit, so earnings power is thin. A PEG of 0.13 depends entirely on that 212% growth continuing, which I doubt. The balance sheet is healthy with debt/equity of just 0.02, and promoter holding at 63.95% is reassuring. The Piotroski score of 6/9 suggests acceptable financial health, but not excellence. Dividend yield is zero, so any return must come from operational improvement. At a P/E of 15.51, the market is not paying a huge premium, but value creation is still missing. This is not a wonderful compounding machine; it is a possible asset-backed turnaround. I need to see ROE climb steadily and quarterly profits scale up before I get excited. A cheap stock can stay cheap for years if capital remains unproductive. I would wait, watch sales momentum, and let the numbers prove the recovery before committing meaningful capital.
Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer